Skip to main content
SpringerLink
Log in

Arteether toxicokinetics and pharmacokinetics in rats after 25 mg/kg/day single and multiple doses

  • Published:
European Journal of Drug Metabolism and Pharmacokinetics Aims and scope Submit manuscript

Summary

Multiple doses of arteether (ARTE) at 25 mg/kg cause CNS and anorectic toxicities in rats. The same dose of ARTE was used to study the toxicokinetics (TK) after multiple injections and the pharmacokinetics (PK) following single administration. Animals were administered ARTE in sesame oil for 7 days, blood samples were collected using destructive sampling for up to 192 h after dosing and assayed by HPLC-ECD. Two other groups of rats were administered either a single 25 mg/kg i.v. or i.m. dose. In addition, the drug remaining in the i.m. injection site was measured. During the 7 day treatments, anorectic toxicity of ARTE was observed, and that caused significant reductions in food consumption and body weight after day 2. TK data on days 2–7 revealed marked changes compared to the PK parameters estimated on day 1. AUC (4367 ng.h/ml) on day 7 was 5-fold higher than AUC (905 ng.h/ml) on day 1. The volume of distribution at steady state (Vss) on day 7 (41.81) was 40% of the day 1 value of the Vss (104.3 1). Clearance (CL) was increased by 89% of the day 1 value, from 0.98 1/h to 1.85 1/h on day 7. The elimination t1/2 of ARTE was also prolonged from 13.7 h (day 1) to 31.2 h (day 7). These data suggest that ARTE may have altered its distribution and elimination in rats as a result of the systemic toxicity. Analysis of the injection sites showed that 38% and 91% of the total amount of ARTE single dose remained in the muscles at 24 h (after first injection) and 168 h (at 24 h after 7 daily multiple doses), respectively. Fast and slow absorption phases from muscle were seen witht1/2 of 0.97 h and 26.3 h, respectively. The apparent elimination t1/2 of ARTE after i.m. injection (13.7 h) was much longer than that after i.v. dosing (0.67 h) due to the prolonged muscle absorption phase. Acute toxicity data of artemisinin drugs demonstrated that animals receiving a high single ARTE dose in sesame oil died between days 5–11, similar to artemether. When animals received dihydroartemisinin formulated in 50% DMAC/oil, or artesunic acid and artelinic acid in 0.9% saline vehicle, they died between days 1 and 2. This suggests that delayed onset toxicity and death in the ARTE rats may also be due to slow absorption and prolonged drug exposure. Therefore multiple i.m. administrations cause anorexia and drug accumulation, possibly affecting the toxicokinetics and efficacy of the drug.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Brewer T.G., Grate S.J., Peggins J.O. et al. (1994): Fatal neurotoxicity of arteether and artemether. Am. J. Trop. Med. Hyg., 51: 251–259.

    PubMed  CAS  Google Scholar 

  2. Petras J.M., Kyle D.E., Ngampochjana M. et al. (1994): Arteether induced brainstem injury in macaca mulatta. Am. J. Trop. Med. Hyg., 51 (Suppl.): 100.

    Google Scholar 

  3. Petras J.M., Kyle D.E., Ngampochjana M. et al. (1997): Arteether: risks of two-week administration in macaca mulatta. Am. J. Trop. Med. Hyg., 57: 390–396.

    Google Scholar 

  4. Genovese R.F., Newman D.B., Li Q-G., Peggins J.O., Brewer T.G. (1998): Dose-dependent brainstem neuropathology following repeated arteether administration in rats. Brain Res. Bull., 45: 199–202.

    Article  PubMed  CAS  Google Scholar 

  5. Brewer T.G., Petras J.M., Peggins J.O. et al. (1993): Differential neurotoxicity of artemisinin analogs in an in vivo model. Am. J. Trop. Med. Hyg., 49 (Suppl.): 292.

    Google Scholar 

  6. Kamchonwongpaisan S., McKeever P., Hossler P., Ziffer H., Meshnick S.R. (1997): Artemisinin neurotoxicity: neuropathology in rats and mechanistic studies in vitro. Am. J. Trop. Med. Hyg., 56: 7–12.

    PubMed  CAS  Google Scholar 

  7. Scientific working group on the chemotherrapy of malaria special programme for research and training in tropical diseases, WHO. (1993): Arteether Injection. 1993 Investigator’s Brochure, Annex H, H3–H7.

  8. Li Q-G., Brewer T.G., Peggins J.O. (1998): Anorectic toxicity of dihydroartemisinin, artemether and arteether in rats following multiple intramuscular doses. Int. J. Toxicol., 17: 322–336.

    Google Scholar 

  9. Kar K., Shankar G., Bajpai R., Dutta G.P., Vishwakarma R.A. (1988): Artemisinin: a potent antimalarial agent, general pharmacological properties. Ind. J. Parasitol., 12: 209–212.

    CAS  Google Scholar 

  10. Yang G.C., Shi W.Z., Li R., Jun G. (1982): The antimalarial and toxic effect of artesunate on animal models. J. Trad. China Med., 2: 99–103.

    CAS  Google Scholar 

  11. Kar K., Nath A., Bajpai R., Dutta G.P., Vishwakarma R.A. (1989): Pharmacology of α/β arteether — a potential antimalarial drug. J. Ethnopharmacol., 27: 297–305.

    Article  PubMed  CAS  Google Scholar 

  12. Qang D., Lin X. (1983): Effect of qinghaosu (artemisinin) suspension in oil on ultrastructure of myocardium in rhesus monkeys. Acta Pharmacol. Sin., 4: 191–194.

    Google Scholar 

  13. Chen L., Wang M., Sun W., Liu M. (1984): Embryotoxicity and teratogenicity studies on artemether in mice, rats and rabbits. Acta Pharmacol. Sin., 5: 118–122.

    CAS  Google Scholar 

  14. Wang T. (1989): Follow-up observation on the therapeutic effects and remote reactions of artemisinin (qinghaosu) and artemether in treating malaria in pregnant woman. J. Trad. China Med., 9: 28–30.

    CAS  Google Scholar 

  15. Myint P.T., Shwe T. (1986): The efficacy of artemether (qinghaosu) inPlasmodium falciparum andP. vivax in Burma. Southeast Asian. J. Trop. Med. Public Health, 17: 19–22.

    Google Scholar 

  16. Myint P.T., Shwe T. (1987): A controlled clinical trial of artemether (qinghaosu derivative) versus quinine in complicated and severe falciparum malaria. Trans. R. Soc. Trop. Med. Hyg., 81: 559–561.

    Article  Google Scholar 

  17. Li G.Q. (1992): Clinical trials on artemisinin and its derivatives in treatment of malaria in China. In: Tharavanij S. et al. (eds) 13th International Congress for Tropical Medicine and Malaria. Abstract 1, 68–69.

  18. Kager P.A., Schultz M.J., Zijlstra E.E., van den Berg B., van Boxtel Ch.J. (1994): Arteether administration in humans: preliminary studies of pharmacokinetics, safety and tolerance. Trans. R. Soc. Trop. Med. Hyg., 88: S1/53–54.

    Article  Google Scholar 

  19. China Cooperative research group on qinghaosu and its derivatives as antimalarials. (1982): Studies on the toxicity of qinghaosu and its derivatives. J. Trad. China Med., 2: 31–38.

    Google Scholar 

  20. China Cooperative research group on qinghaosu and its derivatives as antimalarials. (1982): Clinical studies on the treatment of malaria with qinghaosu and its derivatives. J. Trad. China Med., 2: 45–50.

    Google Scholar 

  21. Valecha N., Gupta S. et al. (1997): Efficacy of alpha, beta-arteether in acute uncomplicatedP. falciparum malaria. Int. J. Clin. Pharmacol. Res., 17: 11–15.

    PubMed  CAS  Google Scholar 

  22. White N.J. (1994): Artemisinin: current status. Trans. R. Soc. Trop. Med. Hyg., 88 (Suppl. 1): S1/3–4.

    Google Scholar 

  23. Nicolosi R.J., Tao L.F., Coleman R.M. (1994): Effect of artemisinin derivative-arteether against experimental schistosomiasis. Am. J. Trop. Med. Hyg., 51 (Suppl.): 194.

    Google Scholar 

  24. Li Q-G., Peggins J.O., Fleckenstein L.L., Masonic K., Heiffer M.H., Brewer T.G. (1998): The pharmacokinetics and bioavailability of dihydroartemisinin, arteether, artemether, artesunic acid and artelinic acid in rats. J. Pharmacy Pharm., 50: 173–182.

    CAS  Google Scholar 

  25. National Research Council (NRC). (1996): Guide for the care and use of laboratory animals. Institute of Laboratory Animal Resources Commission on Life Sciences, NRC. Washington, DC, National Academy Press, 21–55.

    Google Scholar 

  26. Nichols M.B., Maickel R.P. (1989): Amphetamine enantiomers and rat consummatory behavior: A new perspective. Pharmacol. Biochem. Behav., 33: 181–188.

    Article  PubMed  CAS  Google Scholar 

  27. Sakata T., Fukushima K., Tsutsui K., Arase K., Fujimoto K. (1982): Theophylline disrupts diurnal rhythms of humoral factors with loss of meal cyclicity. Physiol. Behav., 28: 641–647.

    Article  PubMed  CAS  Google Scholar 

  28. Gibaldi M., Perrier D. (1982): Multicompartment Models in Pharmacokinetics. New York, Marcel Dekker, 34–55.

    Google Scholar 

  29. Rowland M., Tozer T.N. (1995): Clinical Pharmacokinetics: Concepts and applications. Rowland M., Thomas N. (eds). Tozer, Baltimore, USA: Willianms & Wilkins, 53–105.

    Google Scholar 

  30. Klayman D.L. (1985): Qinghaosu (artemisinin): an antimalarial drug from China. Science, 228: 1049–1055.

    Article  PubMed  CAS  Google Scholar 

  31. Brossi A., Venugopalan B., Gerpe L.D. et al. (1988): Arteether, a new antimalarial drug; synthesis and antimalarial properties. J. Med. Chem., 31: 645–650.

    Article  PubMed  CAS  Google Scholar 

  32. Shargel L., Yu A.B.C. (1993): Applied Biopharmaceutics and Pharmacokinetics. Norwalk, CN: Appleton & Lange, 353–374

    Google Scholar 

  33. Rangan U., Hedli C., Gallo M., Lioy P., Snyder R. (1997): Exposure and risk assessment with respect to contaminated soil: significance of biomarkers and bioavailability. Int. J. Toxicol., 16: 419–432.

    Article  CAS  Google Scholar 

  34. Hanson D.J. (1961): Local toxic effects of broad-spectrum antibiotics following injection. Antibiot. Chemother., 11: 390–404.

    PubMed  CAS  Google Scholar 

  35. Svendsen O. (1982): Local muscle damage and oily vehicles: a study on local reactions in rabbits after intramuscular injection of neuroleptic drugs in aqueous or oily vehicles. Acta Pharmacol. Toxicol., 52: 298–304.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. US Food and Drug Administration, Center for Veterinary Medicine, Maryland, USA

    J. O. Peggins

  2. Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand

    T. G. Brewer

  3. The Department of Pharmacology, Division of Experimental Therapeutics, Walter Reed Army Institute of research, DC 20307-5100, Washington, USA

    Q-G. Li, R. P. Brueckner & K. M. Trotman

Authors
  1. Q-G. Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. P. Brueckner
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. O. Peggins
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. K. M. Trotman
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. T. G. Brewer
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Li, QG., Brueckner, R.P., Peggins, J.O. et al. Arteether toxicokinetics and pharmacokinetics in rats after 25 mg/kg/day single and multiple doses. Eur. J. Drug Metab. Pharmacokinet. 24, 213–223 (1999). https://doi.org/10.1007/BF03190023

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03190023

Keywords

Search

Navigation